Debut

Debut

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://www.debutbiotech.com

Last Round

Early Funding

Aug 26, 2025

Total Funding Raised

$125.2M

Company Overview

Debut (Discovery Tools) is a biotechnology company that offers fully integrated services for ingredient discovery, biofermentation, formulation, and brand creation, utilizing natural enzyme technology to deliver sustainable and cost-effective ingredients at remarkable speed.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Fashion & Beauty, Clean Manufacturing, ML Platforms

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

synthetic biologysynbiocell-free biomanufacturingAI ingredient discoverybiomanufacturingactive ingredientsbiotech beautyprecision fermentationsustainable ingredientsbioactivesformulation servicesclean beautywhite-label manufacturingfragrance ingredientsskin longevityDTC skincarebioindustrial manufacturing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Debut Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Debut Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Early FundingAug 26, 2025
Series BOct 19, 2023
Series BJun 12, 2023
Series AAug 12, 2021
SeedJan 7, 2020

Key People

Founding team and executive leadership

Joshua Britton

Chief Executive Officer

Executive Team

Debut Investors

Notable investors and investment history

InvestorRounds
Fine Structure VenturesSeries A, Series B, Early Funding
FTW VenturesSeed
Cultivian Sandbox VenturesSeries A, Series B
GS FuturesSeries B, Early Funding
Cantos VenturesSeries A
Cavallo VenturesSeries B
EDBIEarly Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 12, 2026

    Derek Wanner appointed as new Chief Commercial Officer.

  • Jul 1, 2025

    Launched a plant cell biotechnology platform for fragrance ingredients.

Debut Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Debut Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Debut's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Diego, California
Employee Range92
Year Founded2019
Last FundingAug 26, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.